From October 16 to October 20, 2020, appointed by the Food and Drug Inspection Center of the State Drug Administration and the Inspection Center of the Shandong Provincial Drug Administration, a six-member inspection team inspected the R&D site of Bainuo Pharmaceuticals and the production site of Lonno Pharmaceuticals A 5-day on-site inspection of drug registration and GMP compliance inspection of desloratadine API was carried out.
Taro`s Generic (Desloratadine 0.5Mg/Ml) Approved in US For Allergy
BUZZ-India`s Dr.Reddy`s up on hopes of US FDA resolution of Srikakulam plant